These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 352612)

  • 21. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ihibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone.
    Corbin A; Beattie CW
    Endocr Res Commun; 1975; 2(1):1-23. PubMed ID: 1097236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of luteinizing hormone (LH), follicle-stimulating hormone, and 17 beta-estradiol in response to D-Trp6-LH-releasing hormone during different phases of the menstrual cycle in normal women.
    Jaramillo CJ; Salgado AC; Perez-Infante V; Puente-Cueva M; Botella-Llusia J; Coy DH; Schally A
    Fertil Steril; 1978 Feb; 29(2):153-8. PubMed ID: 342285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
    Bergquist C; Nillius SJ; Wide L
    Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of LH release with synthetic LH-RH (author's transl)].
    Koyama T
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):881-97. PubMed ID: 828583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LH and FSH responses to luteinizing releasing hormone in normal fertile women.
    Wollesen F; Swerdloff RS; Odell WD
    Metabolism; 1976 Nov; 25(11):1275-85. PubMed ID: 790081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
    Jeppsson S; Rannevik G; Thorell JI
    Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some aspects on pituitary function in human and rat anovulatory cycles.
    Makino T; Shiina M; Ohno T; Iizuka R; Tamaoki B
    Endocrinol Jpn; 1976 Dec; 23(6):445-9. PubMed ID: 798684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary responses to LRH in the postpartum periods.
    Friedman C; Gaeke ME; Fang V; Kim MH
    Am J Obstet Gynecol; 1976 Jan; 124(1):75-9. PubMed ID: 1106206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
    Niaraki MA; Moghissi KS; Borin K
    Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.